{"id":347265,"date":"2025-08-25T11:23:32","date_gmt":"2025-08-25T11:23:32","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-krystal-biotech\/"},"modified":"2025-08-25T11:23:32","modified_gmt":"2025-08-25T11:23:32","slug":"how-to-buy-krystal-biotech","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-krystal-biotech\/","title":{"rendered":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Krystal Biotech, Inc. (KRYS) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Krystal Biotech, Inc. (KRYS)"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334009,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-347265","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Krystal Biotech, Inc. (KRYS) - \u0110\u1ea7u T\u01b0 V\u00e0o C\u1ed5 Phi\u1ebfu Krystal Biotech, Inc. (KRYS)","h1_source":{"label":"H1","type":"text","formatted_value":"C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Krystal Biotech, Inc. (KRYS) - \u0110\u1ea7u T\u01b0 V\u00e0o C\u1ed5 Phi\u1ebfu Krystal Biotech, Inc. (KRYS)"},"description":"T\u00ecm hi\u1ec3u c\u00e1ch mua c\u1ed5 phi\u1ebfu Krystal Biotech, Inc. (KRYS) v\u00e0 \u0111\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu li\u1ec7u ph\u00e1p gen \u0111\u1ea7y h\u1ee9a h\u1eb9n n\u00e0y. Kh\u00e1m ph\u00e1 gi\u00e1 hi\u1ec7n t\u1ea1i, xu h\u01b0\u1edbng v\u00e0 ph\u00e2n t\u00edch chuy\u00ean gia \u0111\u1ec3 \u0111\u01b0a ra quy\u1ebft \u0111\u1ecbnh \u0111\u1ea7u t\u01b0 th\u00f4ng minh.","description_source":{"label":"Description","type":"textarea","formatted_value":"T\u00ecm hi\u1ec3u c\u00e1ch mua c\u1ed5 phi\u1ebfu Krystal Biotech, Inc. (KRYS) v\u00e0 \u0111\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu li\u1ec7u ph\u00e1p gen \u0111\u1ea7y h\u1ee9a h\u1eb9n n\u00e0y. Kh\u00e1m ph\u00e1 gi\u00e1 hi\u1ec7n t\u1ea1i, xu h\u01b0\u1edbng v\u00e0 ph\u00e2n t\u00edch chuy\u00ean gia \u0111\u1ec3 \u0111\u01b0a ra quy\u1ebft \u0111\u1ecbnh \u0111\u1ea7u t\u01b0 th\u00f4ng minh."},"intro":"B\u1ea1n \u0111ang ngh\u0129 \u0111\u1ebfn vi\u1ec7c \u0111\u1ea7u t\u01b0 v\u00e0o t\u01b0\u01a1ng lai c\u1ee7a li\u1ec7u ph\u00e1p gen? Krystal Biotech \u0111\u1ea1i di\u1ec7n cho m\u1ed9t trong nh\u1eefng c\u01a1 h\u1ed9i th\u00fa v\u1ecb nh\u1ea5t trong l\u0129nh v\u1ef1c c\u00f4ng ngh\u1ec7 sinh h\u1ecdc hi\u1ec7n nay. V\u1edbi c\u00e1c ph\u01b0\u01a1ng ph\u00e1p \u0111i\u1ec1u tr\u1ecb \u0111\u1ed9t ph\u00e1 cho c\u00e1c b\u1ec7nh hi\u1ebfm v\u00e0 c\u00e1ch ti\u1ebfp c\u1eadn c\u00e1ch m\u1ea1ng \u0111\u1ed1i v\u1edbi y h\u1ecdc di truy\u1ec1n, c\u00f4ng ty n\u00e0y c\u00f3 th\u1ec3 thay \u0111\u1ed5i c\u1ea3 ng\u00e0nh ch\u0103m s\u00f3c s\u1ee9c kh\u1ecfe v\u00e0 danh m\u1ee5c \u0111\u1ea7u t\u01b0 c\u1ee7a b\u1ea1n. H\u00e3y c\u00f9ng kh\u00e1m ph\u00e1 l\u00fd do t\u1ea1i sao KRYS x\u1ee9ng \u0111\u00e1ng \u0111\u01b0\u1ee3c b\u1ea1n quan t\u00e2m.","intro_source":{"label":"Intro","type":"text","formatted_value":"B\u1ea1n \u0111ang ngh\u0129 \u0111\u1ebfn vi\u1ec7c \u0111\u1ea7u t\u01b0 v\u00e0o t\u01b0\u01a1ng lai c\u1ee7a li\u1ec7u ph\u00e1p gen? Krystal Biotech \u0111\u1ea1i di\u1ec7n cho m\u1ed9t trong nh\u1eefng c\u01a1 h\u1ed9i th\u00fa v\u1ecb nh\u1ea5t trong l\u0129nh v\u1ef1c c\u00f4ng ngh\u1ec7 sinh h\u1ecdc hi\u1ec7n nay. V\u1edbi c\u00e1c ph\u01b0\u01a1ng ph\u00e1p \u0111i\u1ec1u tr\u1ecb \u0111\u1ed9t ph\u00e1 cho c\u00e1c b\u1ec7nh hi\u1ebfm v\u00e0 c\u00e1ch ti\u1ebfp c\u1eadn c\u00e1ch m\u1ea1ng \u0111\u1ed1i v\u1edbi y h\u1ecdc di truy\u1ec1n, c\u00f4ng ty n\u00e0y c\u00f3 th\u1ec3 thay \u0111\u1ed5i c\u1ea3 ng\u00e0nh ch\u0103m s\u00f3c s\u1ee9c kh\u1ecfe v\u00e0 danh m\u1ee5c \u0111\u1ea7u t\u01b0 c\u1ee7a b\u1ea1n. H\u00e3y c\u00f9ng kh\u00e1m ph\u00e1 l\u00fd do t\u1ea1i sao KRYS x\u1ee9ng \u0111\u00e1ng \u0111\u01b0\u1ee3c b\u1ea1n quan t\u00e2m."},"body_html":"<h2>\ud83d\udcc8 C\u1ed5 Phi\u1ebfu Krystal Biotech: Gi\u00e1 Hi\u1ec7n T\u1ea1i v\u00e0 V\u1ecb Th\u1ebf Th\u1ecb Tr\u01b0\u1eddng<\/h2> <p>T\u00ednh \u0111\u1ebfn ng\u00e0y 25 th\u00e1ng 8 n\u0103m 2025, Krystal Biotech, Inc. (KRYS) giao d\u1ecbch \u1edf m\u1ee9c <strong>146,04 USD<\/strong> tr\u00ean s\u00e0n NASDAQ. M\u1ee9c gi\u00e1 n\u00e0y \u0111\u1ea1i di\u1ec7n cho m\u1ed9t \u0111i\u1ec3m v\u00e0o h\u1ea5p d\u1eabn khi xem x\u00e9t hi\u1ec7u su\u1ea5t g\u1ea7n \u0111\u00e2y v\u00e0 ti\u1ec1m n\u0103ng t\u01b0\u01a1ng lai c\u1ee7a c\u1ed5 phi\u1ebfu.<\/p> <p><strong>C\u1ea3nh B\u00e1o Ng\u00e0y Quan Tr\u1ecdng:<\/strong> H\u00e3y \u0111\u00e1nh d\u1ea5u <strong>ng\u00e0y 3 th\u00e1ng 11 n\u0103m 2025<\/strong> v\u00e0o l\u1ecbch c\u1ee7a b\u1ea1n. \u0110\u00e2y l\u00e0 ng\u00e0y Krystal Biotech c\u00f4ng b\u1ed1 b\u00e1o c\u00e1o thu nh\u1eadp ti\u1ebfp theo tr\u01b0\u1edbc khi th\u1ecb tr\u01b0\u1eddng m\u1edf c\u1eeda. L\u1ecbch s\u1eed cho th\u1ea5y c\u00e1c th\u00f4ng b\u00e1o n\u00e0y th\u01b0\u1eddng t\u1ea1o ra bi\u1ebfn \u0111\u1ed9ng gi\u00e1 \u0111\u00e1ng k\u1ec3.<\/p> <h3>C\u00e1ch B\u00e1o C\u00e1o Thu Nh\u1eadp \u1ea2nh H\u01b0\u1edfng \u0110\u1ebfn C\u1ed5 Phi\u1ebfu KRYS<\/h3> <p>Xem x\u00e9t l\u1ecbch s\u1eed g\u1ea7n \u0111\u00e2y, c\u00e1c b\u00e1o c\u00e1o thu nh\u1eadp c\u1ee7a Krystal Biotech \u0111\u00e3 li\u00ean t\u1ee5c t\u00e1c \u0111\u1ed9ng \u0111\u1ebfn c\u1ed5 phi\u1ebfu:<\/p> <table> <thead> <tr><th>Ng\u00e0y<\/th><th>S\u1ef1 Ki\u1ec7n<\/th><th>Gi\u00e1 Tr\u01b0\u1edbc Tin<\/th><th>Thay \u0110\u1ed5i Sau Tin<\/th><\/tr> <\/thead> <tbody> <tr><td>4 th\u00e1ng 8, 2025<\/td><td>B\u00e1o c\u00e1o Q2<\/td><td>138,66 USD<\/td><td>+2,56 (+1,88%)<\/td><\/tr> <tr><td>5 th\u00e1ng 5, 2025<\/td><td>B\u00e1o c\u00e1o Q1<\/td><td>142,10 USD<\/td><td>-3,44 (-2,42%)<\/td><\/tr> <tr><td>10 th\u00e1ng 2, 2025<\/td><td>K\u1ebft qu\u1ea3 h\u00e0ng n\u0103m<\/td><td>148,90 USD<\/td><td>+5,20 (+3,49%)<\/td><\/tr> <tr><td>4 th\u00e1ng 11, 2024<\/td><td>B\u00e1o c\u00e1o Q3<\/td><td>140,25 USD<\/td><td>+7,85 (+5,60%)<\/td><\/tr> <tr><td>5 th\u00e1ng 8, 2024<\/td><td>B\u00e1o c\u00e1o Q2<\/td><td>132,40 USD<\/td><td>+8,26 (+6,24%)<\/td><\/tr> <tr><td>6 th\u00e1ng 5, 2024<\/td><td>B\u00e1o c\u00e1o Q1<\/td><td>125,80 USD<\/td><td>+6,60 (+5,25%)<\/td><\/tr> <\/tbody> <\/table> <p><strong>Nh\u1eadn \u0110\u1ecbnh Xu H\u01b0\u1edbng:<\/strong> B\u00e1o c\u00e1o thu nh\u1eadp ng\u00e0y 4 th\u00e1ng 8 n\u0103m 2025 \u0111\u1eb7c bi\u1ec7t \u1ea5n t\u01b0\u1ee3ng - c\u00f4ng ty b\u00e1o c\u00e1o EPS l\u00e0 1,29 USD so v\u1edbi \u01b0\u1edbc t\u00ednh 1,08 USD (b\u1ea5t ng\u1edd 19,44%) v\u00e0 doanh thu 96,04 tri\u1ec7u USD so v\u1edbi \u01b0\u1edbc t\u00ednh 95,42 tri\u1ec7u USD (<a href=\"https:\/\/www.nasdaq.com\/articles\/krystal-biotech-inc-krys-tops-q2-earnings-and-revenue-estimates\">B\u00e1o c\u00e1o Nasdaq<\/a>). M\u1eb7c d\u00f9 hi\u1ec7u su\u1ea5t m\u1ea1nh m\u1ebd n\u00e0y, c\u1ed5 phi\u1ebfu ch\u1ec9 t\u0103ng 1,88%, cho th\u1ea5y kh\u1ea3 n\u0103ng b\u1ecb \u0111\u1ecbnh gi\u00e1 th\u1ea5p.<\/p> <h3>H\u00e0nh Tr\u00ecnh Gi\u00e1 6 Th\u00e1ng (Th\u00e1ng 2 - Th\u00e1ng 8 N\u0103m 2025)<\/h3> <p>Krystal Biotech \u0111\u00e3 tr\u1ea3i qua bi\u1ebfn \u0111\u1ed9ng \u0111\u00e1ng k\u1ec3 trong s\u00e1u th\u00e1ng qua:<\/p> <p><strong>Th\u00e1ng 2 n\u0103m 2025:<\/strong> 148,90 USD - K\u1ebft qu\u1ea3 h\u00e0ng n\u0103m m\u1ea1nh m\u1ebd t\u0103ng s\u1ef1 t\u1ef1 tin<br\/> <strong>Th\u00e1ng 3 n\u0103m 2025:<\/strong> 142,30 USD - S\u1ef1 \u0111i\u1ec1u ch\u1ec9nh th\u1ecb tr\u01b0\u1eddng \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn ng\u00e0nh c\u00f4ng ngh\u1ec7 sinh h\u1ecdc<br\/> <strong>Th\u00e1ng 4 n\u0103m 2025:<\/strong> 138,75 USD - \u00c1p l\u1ef1c ti\u1ebfp t\u1ee5c tr\u00ean to\u00e0n ng\u00e0nh<br\/> <strong>Th\u00e1ng 5 n\u0103m 2025:<\/strong> 142,10 USD - B\u00e1o c\u00e1o Q1 h\u1ed7 tr\u1ee3 gi\u00e1<br\/> <strong>Th\u00e1ng 6 n\u0103m 2025:<\/strong> 136,50 USD - Giai \u0111o\u1ea1n bi\u1ebfn \u0111\u1ed9ng m\u00f9a h\u00e8<br\/> <strong>Th\u00e1ng 7 n\u0103m 2025:<\/strong> 140,80 USD - B\u1eaft \u0111\u1ea7u ph\u1ee5c h\u1ed3i d\u1ea7n<br\/> <strong>Th\u00e1ng 8 n\u0103m 2025:<\/strong> 146,04 USD - M\u1ee9c hi\u1ec7n t\u1ea1i v\u1edbi s\u1ef1 t\u0103ng tr\u01b0\u1edfng t\u1eeb b\u00e1o c\u00e1o thu nh\u1eadp g\u1ea7n \u0111\u00e2y<\/p> <p>C\u1ed5 phi\u1ebfu \u0111\u00e3 gi\u1ea3m kho\u1ea3ng <strong>12,59%<\/strong> t\u1eeb \u0111\u1ea7u n\u0103m 2025 (<a href=\"https:\/\/companiesmarketcap.com\/krystal-biotech\/stock-price-history\/\">CompaniesMarketCap<\/a>), nh\u01b0ng \u0111i\u1ec1u n\u00e0y di\u1ec5n ra sau nh\u1eefng n\u0103m hi\u1ec7u su\u1ea5t xu\u1ea5t s\u1eafc - bao g\u1ed3m m\u1ee9c t\u0103ng 25,37% n\u0103m 2024 v\u00e0 l\u1ee3i nhu\u1eadn \u1ea5n t\u01b0\u1ee3ng 56,58% n\u0103m 2023.<\/p> [cta_green text=\"B\u1eaft \u0111\u1ea7u giao d\u1ecbch\"]<h2>\ud83d\udd2e D\u1ef1 B\u00e1o Gi\u00e1: Tri\u1ec3n V\u1ecdng 2025-2030<\/h2> <p>D\u1ef1a tr\u00ean d\u1ef1 b\u00e1o hi\u1ec7n t\u1ea1i c\u1ee7a c\u00e1c nh\u00e0 ph\u00e2n t\u00edch v\u00e0 n\u1ec1n t\u1ea3ng c\u00f4ng ty, \u0111\u00e2y l\u00e0 nh\u1eefng g\u00ec b\u1ea1n c\u00f3 th\u1ec3 mong \u0111\u1ee3i:<\/p> <ul> <li><strong>Cu\u1ed1i n\u0103m 2025:<\/strong> M\u1ee9c gi\u00e1 168-172 USD (t\u0103ng 15-18% so v\u1edbi m\u1ee9c hi\u1ec7n t\u1ea1i)<\/li> <li><strong>M\u1ee5c ti\u00eau 2026:<\/strong> 190-195 USD (t\u0103ng tr\u01b0\u1edfng ti\u1ec1m n\u0103ng 30-33%)<\/li> <li><strong>D\u1ef1 b\u00e1o 2028:<\/strong> 240-260 USD (t\u0103ng gi\u00e1 d\u00e0i h\u1ea1n 64-78%)<\/li> <li><strong>Tri\u1ec3n v\u1ecdng 2030:<\/strong> 295-320 USD (ti\u1ec1m n\u0103ng l\u1ee3i nhu\u1eadn t\u1ed5ng c\u1ed9ng 102-119%)<\/li> <\/ul> <p>D\u1ef1 b\u00e1o l\u1ea1c quan nh\u1ea5t \u0111\u1ebfn t\u1eeb <a href=\"https:\/\/stockscan.io\/stocks\/KRYS\/forecast\">StockScan<\/a>, d\u1ef1 \u0111o\u00e1n gi\u00e1 trung b\u00ecnh 264,25 USD n\u0103m 2025 v\u1edbi m\u1ee5c ti\u00eau cao nh\u1ea5t l\u00e0 300,56 USD.<\/p> <p><strong>K\u1ebft lu\u1eadn: MUA M\u1ea0NH<\/strong> - \u0110\u1ed3ng thu\u1eadn hi\u1ec7n t\u1ea1i c\u1ee7a c\u00e1c nh\u00e0 ph\u00e2n t\u00edch cho th\u1ea5y 11 nh\u00e0 ph\u00e2n t\u00edch \u0111\u00e1nh gi\u00e1 \"Mua M\u1ea1nh\" v\u1edbi m\u1ee5c ti\u00eau gi\u00e1 trung b\u00ecnh 205,27 USD, t\u01b0\u01a1ng \u1ee9ng ti\u1ec1m n\u0103ng t\u0103ng 40,60% (<a href=\"https:\/\/stockanalysis.com\/stocks\/krys\/forecast\/\">StockAnalysis<\/a>).<\/p> <h2>\u26a0\ufe0f R\u1ee7i Ro Ch\u00ednh v\u00e0 T\u00edn Hi\u1ec7u T\u00edch C\u1ef1c<\/h2> <h3>R\u1ee7i Ro C\u1ea7n L\u01b0u \u00dd<\/h3> <ul> <li><strong>Bi\u1ebfn \u0111\u1ed9ng cao:<\/strong> C\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc v\u1ed1n r\u1ea5t bi\u1ebfn \u0111\u1ed9ng - KRYS c\u00f3 ph\u1ea1m vi 52 tu\u1ea7n t\u1eeb 122,80 USD \u0111\u1ebfn 207,84 USD, t\u01b0\u01a1ng \u0111\u01b0\u01a1ng h\u01a1n 69% bi\u1ebfn \u0111\u1ed9ng<\/li> <li><strong>B\u1ea5t \u0111\u1ecbnh v\u1ec1 quy \u0111\u1ecbnh:<\/strong> Li\u1ec7u ph\u00e1p gen ch\u1ecbu s\u1ef1 gi\u00e1m s\u00e1t nghi\u00eam ng\u1eb7t c\u1ee7a FDA - b\u1ea5t k\u1ef3 tr\u1edf ng\u1ea1i n\u00e0o v\u1ec1 quy \u0111\u1ecbnh \u0111\u1ec1u c\u00f3 th\u1ec3 \u1ea3nh h\u01b0\u1edfng l\u1edbn \u0111\u1ebfn c\u1ed5 phi\u1ebfu<\/li> <li><strong>R\u1ee7i ro th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng:<\/strong> Ch\u01b0\u01a1ng tr\u00ecnh KB707 \u0111i\u1ec1u tr\u1ecb ung th\u01b0 ph\u1ed5i, d\u00f9 \u0111\u1ea7y h\u1ee9a h\u1eb9n, v\u1eabn \u0111ang trong giai \u0111o\u1ea1n \u0111\u1ea7u v\u00e0 c\u00f3 th\u1ec3 g\u1eb7p th\u00e1ch th\u1ee9c ph\u00e1t tri\u1ec3n<\/li> <li><strong>T\u00e2m l\u00fd th\u1ecb tr\u01b0\u1eddng:<\/strong> T\u00e2m l\u00fd ng\u00e0nh c\u00f4ng ngh\u1ec7 sinh h\u1ecdc v\u1eabn th\u1eadn tr\u1ecdng m\u1eb7c d\u00f9 n\u1ec1n t\u1ea3ng v\u1eefng ch\u1eafc<\/li> <\/ul> <h3>T\u00edn Hi\u1ec7u T\u00edch C\u1ef1c Cho 2025-2026<\/h3> <ul> <li><strong>T\u00e0i ch\u00ednh m\u1ea1nh m\u1ebd:<\/strong> Qu\u00fd 2 n\u0103m 2025 cho th\u1ea5y doanh thu t\u0103ng 37% so v\u1edbi c\u00f9ng k\u1ef3 l\u00ean 96,0 tri\u1ec7u USD v\u00e0 l\u1ee3i nhu\u1eadn r\u00f2ng t\u0103ng 146% l\u00ean 38,3 tri\u1ec7u USD<\/li> <li><strong>Li\u1ec7u ph\u00e1p \u0111\u1ed9t ph\u00e1:<\/strong> VYJUVEK l\u00e0 li\u1ec7u ph\u00e1p gen \u0111\u1ea7u ti\u00ean \u0111\u01b0\u1ee3c FDA ph\u00ea duy\u1ec7t cho b\u1ec7nh lo\u00e9t da b\u00f3ng n\u01b0\u1edbc d\u1ea1ng dystrophic, mang l\u1ea1i doanh thu b\u1ec1n v\u1eefng<\/li> <li><strong>Ti\u1ebfn tri\u1ec3n trong pipeline:<\/strong> Ch\u01b0\u01a1ng tr\u00ecnh KB707 d\u1ea1ng h\u00edt \u0111i\u1ec1u tr\u1ecb ung th\u01b0 ph\u1ed5i cho th\u1ea5y t\u1ef7 l\u1ec7 \u0111\u00e1p \u1ee9ng kh\u00e1ch quan 36% v\u00e0 h\u1ed3 s\u01a1 an to\u00e0n xu\u1ea5t s\u1eafc (<a href=\"https:\/\/www.pharmanow.live\/latest-news\/kb707-lung-cancer-update\">PharmaNow<\/a>)<\/li> <li><strong>H\u1ed7 tr\u1ee3 t\u1eeb nh\u00e0 ph\u00e2n t\u00edch:<\/strong> Ni\u1ec1m tin c\u1ee7a c\u00e1c t\u1ed5 ch\u1ee9c ng\u00e0y c\u00e0ng t\u0103ng v\u1edbi nhi\u1ec1u \u0111\u00e1nh gi\u00e1 \"Mua M\u1ea1nh\" h\u01a1n<\/li> <li><strong>Xu h\u01b0\u1edbng ng\u00e0nh:<\/strong> Th\u1ecb tr\u01b0\u1eddng li\u1ec7u ph\u00e1p gen d\u1ef1 ki\u1ebfn t\u0103ng tr\u01b0\u1edfng 26% h\u00e0ng n\u0103m trong ba n\u0103m t\u1edbi<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f Nh\u00e0 Giao D\u1ecbch M\u1edbi N\u00ean L\u00e0m G\u00ec H\u00f4m Nay?<\/h2> <p>D\u1ef1a tr\u00ean ph\u00e2n t\u00edch c\u1ee7a t\u00f4i v\u1ec1 t\u1ea5t c\u1ea3 c\u00e1c y\u1ebfu t\u1ed1 n\u00e0y, \u0111\u00e2y l\u00e0 l\u1eddi khuy\u00ean c\u1ee7a t\u00f4i:<\/p> <ol> <li><strong>B\u1eaft \u0111\u1ea7u nh\u1ecf:<\/strong> B\u1eaft \u0111\u1ea7u v\u1edbi v\u1ecb th\u1ebf kh\u00f4ng v\u01b0\u1ee3t qu\u00e1 3-5% t\u1ed5ng danh m\u1ee5c \u0111\u1ea7u t\u01b0 c\u1ee7a b\u1ea1n<\/li> <li><strong>Trung b\u00ecnh gi\u00e1 mua:<\/strong> Thay v\u00ec mua m\u1ed9t l\u1ea7n, h\u00e3y chia nh\u1ecf c\u00e1c l\u1ea7n mua trong v\u00e0i tu\u1ea7n \u0111\u1ec3 trung b\u00ecnh gi\u00e1 v\u00e0o<\/li> <li><strong>\u0110\u1eb7t l\u1ec7nh d\u1eebng l\u1ed7:<\/strong> Do bi\u1ebfn \u0111\u1ed9ng cao, h\u00e3y b\u1ea3o v\u1ec7 kho\u1ea3n \u0111\u1ea7u t\u01b0 v\u1edbi m\u1ee9c d\u1eebng l\u1ed7 kho\u1ea3ng 135-140 USD<\/li> <li><strong>Theo d\u00f5i ng\u00e0y 3 th\u00e1ng 11:<\/strong> B\u00e1o c\u00e1o thu nh\u1eadp ti\u1ebfp theo c\u00f3 th\u1ec3 cung c\u1ea5p \u0111i\u1ec3m v\u00e0o t\u1ed1t h\u01a1n n\u1ebfu c\u00f3 s\u1ef1 suy y\u1ebfu t\u1ea1m th\u1eddi<\/li> <\/ol> <p>Ch\u00e2m ng\u00f4n h\u00e0i h\u01b0\u1edbc d\u00e0nh cho nh\u00e0 giao d\u1ecbch: \"Mua c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc gi\u1ed1ng nh\u01b0 h\u1eb9n h\u00f2 - \u0111\u00f4i khi b\u1ea1n ph\u1ea3i ch\u1ecbu \u0111\u1ef1ng nh\u1eefng drama \u0111\u1ec3 t\u1eadn h\u01b0\u1edfng ph\u1ea7n th\u01b0\u1edfng m\u1ed1i quan h\u1ec7 l\u00e2u d\u00e0i!\"<\/p> <h2>\u2705 C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Krystal Biotech, Inc. (KRYS) - T\u1eebng B\u01b0\u1edbc<\/h2> <table> <thead> <tr><th>B\u01b0\u1edbc<\/th><th>H\u00e0nh \u0110\u1ed9ng<\/th><th>T\u1ea1i Sao Quan Tr\u1ecdng<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Ch\u1ecdn N\u1ec1n T\u1ea3ng Giao D\u1ecbch<\/td><td>\u0110\u1ea3m b\u1ea3o n\u1ec1n t\u1ea3ng cung c\u1ea5p c\u1ed5 phi\u1ebfu ni\u00eam y\u1ebft tr\u00ean NASDAQ v\u00e0 c\u00f3 ph\u00ed h\u1ee3p l\u00fd<\/td><\/tr> <tr><td>2<\/td><td>M\u1edf v\u00e0 N\u1ea1p Ti\u1ec1n V\u00e0o T\u00e0i Kho\u1ea3n<\/td><td>B\u1eaft \u0111\u1ea7u v\u1edbi s\u1ed1 ti\u1ec1n b\u1ea1n c\u1ea3m th\u1ea5y tho\u1ea3i m\u00e1i r\u1ee7i ro - ngay c\u1ea3 100 USD c\u0169ng c\u00f3 th\u1ec3 gi\u00fap b\u1ea1n b\u1eaft \u0111\u1ea7u<\/td><\/tr> <tr><td>3<\/td><td>T\u00ecm ki\u1ebfm \"KRYS\"<\/td><td>S\u1eed d\u1ee5ng m\u00e3 ch\u1ee9ng kho\u00e1n, kh\u00f4ng ch\u1ec9 t\u00ean c\u00f4ng ty<\/td><\/tr> <tr><td>4<\/td><td>Ch\u1ecdn Lo\u1ea1i L\u1ec7nh<\/td><td>D\u00f9ng l\u1ec7nh gi\u1edbi h\u1ea1n \u0111\u1ec3 ki\u1ec3m so\u00e1t gi\u00e1 v\u00e0o thay v\u00ec l\u1ec7nh th\u1ecb tr\u01b0\u1eddng<\/td><\/tr> <tr><td>5<\/td><td>Xem l\u1ea1i v\u00e0 X\u00e1c nh\u1eadn<\/td><td>Ki\u1ec3m tra k\u1ef9 chi ti\u1ebft l\u1ec7nh v\u00e0 ph\u00ed hoa h\u1ed3ng tr\u01b0\u1edbc khi th\u1ef1c hi\u1ec7n<\/td><\/tr> <tr><td>6<\/td><td>\u0110\u1eb7t C\u1ea3nh B\u00e1o Gi\u00e1<\/td><td>Theo d\u00f5i kho\u1ea3n \u0111\u1ea7u t\u01b0 v\u1edbi th\u00f4ng b\u00e1o t\u1ef1 \u0111\u1ed9ng khi gi\u00e1 bi\u1ebfn \u0111\u1ed9ng l\u1edbn<\/td><\/tr> <tr><td>7<\/td><td>L\u1eadp K\u1ebf Ho\u1ea1ch Tho\u00e1t L\u1ec7nh<\/td><td>Quy\u1ebft \u0111\u1ecbnh tr\u01b0\u1edbc khi b\u1ea1n s\u1ebd ch\u1ed1t l\u1eddi ho\u1eb7c c\u1eaft l\u1ed7<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 T\u1ea1i Sao Pocket Option Ph\u00f9 H\u1ee3p V\u1edbi Nh\u00e0 \u0110\u1ea7u T\u01b0 M\u1edbi<\/h2> <p>\u0110\u1ed1i v\u1edbi nh\u1eefng ng\u01b0\u1eddi mu\u1ed1n b\u1eaft \u0111\u1ea7u h\u00e0nh tr\u00ecnh \u0111\u1ea7u t\u01b0 v\u1edbi Krystal Biotech, Pocket Option mang l\u1ea1i nhi\u1ec1u l\u1ee3i th\u1ebf:<\/p> <ul> <li><strong>S\u1ed1 ti\u1ec1n n\u1ea1p t\u1ed1i thi\u1ec3u ch\u1ec9 5 USD<\/strong> - ho\u00e0n h\u1ea3o \u0111\u1ec3 th\u1eed nghi\u1ec7m chi\u1ebfn l\u01b0\u1ee3c v\u1edbi r\u1ee7i ro th\u1ea5p<\/li> <li><strong>Quy tr\u00ecnh KYC nhanh nh\u01b0 ch\u1edbp<\/strong> - x\u00e1c minh ch\u1ec9 v\u1edbi m\u1ed9t t\u00e0i li\u1ec7u trong v\u00e0i ph\u00fat<\/li> <li><strong>H\u00e0ng tr\u0103m ph\u01b0\u01a1ng th\u1ee9c r\u00fat ti\u1ec1n<\/strong> bao g\u1ed3m ti\u1ec1n \u0111i\u1ec7n t\u1eed, v\u00ed \u0111i\u1ec7n t\u1eed v\u00e0 c\u00e1c ph\u01b0\u01a1ng th\u1ee9c ng\u00e2n h\u00e0ng truy\u1ec1n th\u1ed1ng<\/li> <li><strong>N\u1ec1n t\u1ea3ng th\u00e2n thi\u1ec7n v\u1edbi ng\u01b0\u1eddi d\u00f9ng<\/strong> thi\u1ebft k\u1ebf ri\u00eang cho ng\u01b0\u1eddi m\u1edbi v\u1edbi t\u00e0i nguy\u00ean gi\u00e1o d\u1ee5c<\/li> <\/ul> <p>R\u00e0o c\u1ea3n gia nh\u1eadp th\u1ea5p c\u1ee7a n\u1ec1n t\u1ea3ng l\u00e0m cho n\u00f3 l\u00fd t\u01b0\u1edfng cho c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 mu\u1ed1n x\u00e2y d\u1ef1ng v\u1ecb th\u1ebf d\u1ea7n d\u1ea7n trong khi h\u1ecdc v\u1ec1 \u0111\u1ea7u t\u01b0 c\u00f4ng ngh\u1ec7 sinh h\u1ecdc.<\/p> <h2>\ud83c\udf0d Krystal Biotech N\u0103m 2025: Ng\u01b0\u1eddi Ti\u00ean Phong Li\u1ec7u Ph\u00e1p Gen<\/h2> <p>Krystal Biotech \u0111\u00e3 kh\u1eb3ng \u0111\u1ecbnh m\u00ecnh l\u00e0 m\u1ed9t <strong>c\u00f4ng ty li\u1ec7u ph\u00e1p gen giai \u0111o\u1ea1n th\u01b0\u01a1ng m\u1ea1i<\/strong> v\u1edbi v\u1ed1n h\u00f3a th\u1ecb tr\u01b0\u1eddng kho\u1ea3ng 4,5 t\u1ef7 USD (<a href=\"https:\/\/www.bccresearch.com\/company-index\/profile\/krystal-biotech-inc\">BCC Research<\/a>). C\u00f4ng ty chuy\u00ean ph\u00e1t tri\u1ec3n c\u00e1c lo\u1ea1i thu\u1ed1c di truy\u1ec1n cho c\u00e1c b\u1ec7nh hi\u1ebfm s\u1eed d\u1ee5ng c\u00f4ng ngh\u1ec7 vector HSV-1 \u0111\u1ed9c quy\u1ec1n c\u1ee7a m\u00ecnh.<\/p> <p><strong>\u0110i\u1ec1u g\u00ec l\u00e0m h\u1ecd \u0111\u1eb7c bi\u1ec7t?<\/strong> N\u1ec1n t\u1ea3ng STAR-D c\u1ee7a h\u1ecd cho ph\u00e9p li\u1ec7u ph\u00e1p gen c\u00f3 th\u1ec3 t\u00e1i s\u1eed d\u1ee5ng - ngh\u0129a l\u00e0 b\u1ec7nh nh\u00e2n c\u00f3 th\u1ec3 nh\u1eadn nhi\u1ec1u l\u1ea7n \u0111i\u1ec1u tr\u1ecb m\u00e0 kh\u00f4ng ph\u00e1t tri\u1ec3n kh\u00e1ng th\u1ec3 mi\u1ec5n d\u1ecbch, m\u1ed9t b\u01b0\u1edbc \u0111\u1ed9t ph\u00e1 l\u1edbn trong l\u0129nh v\u1ef1c n\u00e0y.<\/p> <p>S\u1ea3n ph\u1ea9m ch\u1ee7 l\u1ef1c c\u1ee7a c\u00f4ng ty, VYJUVEK, l\u00e0 <strong>li\u1ec7u ph\u00e1p gen \u0111\u1ea7u ti\u00ean \u0111\u01b0\u1ee3c FDA ph\u00ea duy\u1ec7t<\/strong> cho b\u1ec7nh lo\u00e9t da b\u00f3ng n\u01b0\u1edbc d\u1ea1ng dystrophic, m\u1ed9t r\u1ed1i lo\u1ea1n da di truy\u1ec1n \u0111au \u0111\u1edbn v\u00e0 suy nh\u01b0\u1ee3c. Nh\u01b0ng \u0111i\u1ec1u th\u1ef1c s\u1ef1 g\u00e2y ph\u1ea5n kh\u00edch l\u00e0 pipeline c\u1ee7a h\u1ecd, \u0111\u1eb7c bi\u1ec7t l\u00e0 ch\u01b0\u01a1ng tr\u00ecnh KB707 cho ung th\u01b0 ph\u1ed5i kh\u00f4ng t\u1ebf b\u00e0o nh\u1ecf \u0111ang cho th\u1ea5y k\u1ebft qu\u1ea3 s\u1edbm \u0111\u00e1ng ch\u00fa \u00fd.<\/p> <h3>S\u1ef1 Th\u1eadt Th\u00fa V\u1ecb:<\/h3> <p>V\u00e0o th\u00e1ng 8 n\u0103m 2025, Krystal Biotech \u0111\u00e3 g\u00e2y ch\u00fa \u00fd khi \u01b0u ti\u00ean li\u1ec7u ph\u00e1p KB707 d\u1ea1ng h\u00edt cho ung th\u01b0 ph\u1ed5i sau khi n\u00f3 th\u1ec3 hi\u1ec7n t\u1ef7 l\u1ec7 \u0111\u00e1p \u1ee9ng 36% \u1edf b\u1ec7nh nh\u00e2n \u0111\u00e3 \u0111i\u1ec1u tr\u1ecb nhi\u1ec1u l\u1ea7n. \u0110i\u1ec1u g\u00ec th\u1ef1c s\u1ef1 \u0111\u00e1ng ch\u00fa \u00fd? Li\u1ec7u ph\u00e1p n\u00e0y c\u00f3 th\u1ec3 \u0111\u01b0\u1ee3c s\u1eed d\u1ee5ng trong m\u00f4i tr\u01b0\u1eddng ngo\u1ea1i tr\u00fa m\u00e0 kh\u00f4ng c\u00f3 t\u00e1c d\u1ee5ng ph\u1ee5 nghi\u00eam tr\u1ecdng - c\u00f3 kh\u1ea3 n\u0103ng c\u00e1ch m\u1ea1ng h\u00f3a kh\u1ea3 n\u0103ng ti\u1ebfp c\u1eadn \u0111i\u1ec1u tr\u1ecb ung th\u01b0 (<a href=\"https:\/\/www.globenewswire.com\/news-release\/2025\/08\/21\/3137361\/0\/en\/Krystal-Biotech-Announces-Update-on-Development-Plans-for-Oncology-Program-KB707-and-Prioritization-of-Inhaled-KB707-for-the-Treatment-of-Non-Small-Cell-Lung-Cancer.html\">GlobeNewswire<\/a>).<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 C\u1ed5 Phi\u1ebfu Krystal Biotech: Gi\u00e1 Hi\u1ec7n T\u1ea1i v\u00e0 V\u1ecb Th\u1ebf Th\u1ecb Tr\u01b0\u1eddng<\/h2>\n<p>T\u00ednh \u0111\u1ebfn ng\u00e0y 25 th\u00e1ng 8 n\u0103m 2025, Krystal Biotech, Inc. (KRYS) giao d\u1ecbch \u1edf m\u1ee9c <strong>146,04 USD<\/strong> tr\u00ean s\u00e0n NASDAQ. M\u1ee9c gi\u00e1 n\u00e0y \u0111\u1ea1i di\u1ec7n cho m\u1ed9t \u0111i\u1ec3m v\u00e0o h\u1ea5p d\u1eabn khi xem x\u00e9t hi\u1ec7u su\u1ea5t g\u1ea7n \u0111\u00e2y v\u00e0 ti\u1ec1m n\u0103ng t\u01b0\u01a1ng lai c\u1ee7a c\u1ed5 phi\u1ebfu.<\/p>\n<p><strong>C\u1ea3nh B\u00e1o Ng\u00e0y Quan Tr\u1ecdng:<\/strong> H\u00e3y \u0111\u00e1nh d\u1ea5u <strong>ng\u00e0y 3 th\u00e1ng 11 n\u0103m 2025<\/strong> v\u00e0o l\u1ecbch c\u1ee7a b\u1ea1n. \u0110\u00e2y l\u00e0 ng\u00e0y Krystal Biotech c\u00f4ng b\u1ed1 b\u00e1o c\u00e1o thu nh\u1eadp ti\u1ebfp theo tr\u01b0\u1edbc khi th\u1ecb tr\u01b0\u1eddng m\u1edf c\u1eeda. L\u1ecbch s\u1eed cho th\u1ea5y c\u00e1c th\u00f4ng b\u00e1o n\u00e0y th\u01b0\u1eddng t\u1ea1o ra bi\u1ebfn \u0111\u1ed9ng gi\u00e1 \u0111\u00e1ng k\u1ec3.<\/p>\n<h3>C\u00e1ch B\u00e1o C\u00e1o Thu Nh\u1eadp \u1ea2nh H\u01b0\u1edfng \u0110\u1ebfn C\u1ed5 Phi\u1ebfu KRYS<\/h3>\n<p>Xem x\u00e9t l\u1ecbch s\u1eed g\u1ea7n \u0111\u00e2y, c\u00e1c b\u00e1o c\u00e1o thu nh\u1eadp c\u1ee7a Krystal Biotech \u0111\u00e3 li\u00ean t\u1ee5c t\u00e1c \u0111\u1ed9ng \u0111\u1ebfn c\u1ed5 phi\u1ebfu:<\/p>\n<table>\n<thead>\n<tr>\n<th>Ng\u00e0y<\/th>\n<th>S\u1ef1 Ki\u1ec7n<\/th>\n<th>Gi\u00e1 Tr\u01b0\u1edbc Tin<\/th>\n<th>Thay \u0110\u1ed5i Sau Tin<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>4 th\u00e1ng 8, 2025<\/td>\n<td>B\u00e1o c\u00e1o Q2<\/td>\n<td>138,66 USD<\/td>\n<td>+2,56 (+1,88%)<\/td>\n<\/tr>\n<tr>\n<td>5 th\u00e1ng 5, 2025<\/td>\n<td>B\u00e1o c\u00e1o Q1<\/td>\n<td>142,10 USD<\/td>\n<td>-3,44 (-2,42%)<\/td>\n<\/tr>\n<tr>\n<td>10 th\u00e1ng 2, 2025<\/td>\n<td>K\u1ebft qu\u1ea3 h\u00e0ng n\u0103m<\/td>\n<td>148,90 USD<\/td>\n<td>+5,20 (+3,49%)<\/td>\n<\/tr>\n<tr>\n<td>4 th\u00e1ng 11, 2024<\/td>\n<td>B\u00e1o c\u00e1o Q3<\/td>\n<td>140,25 USD<\/td>\n<td>+7,85 (+5,60%)<\/td>\n<\/tr>\n<tr>\n<td>5 th\u00e1ng 8, 2024<\/td>\n<td>B\u00e1o c\u00e1o Q2<\/td>\n<td>132,40 USD<\/td>\n<td>+8,26 (+6,24%)<\/td>\n<\/tr>\n<tr>\n<td>6 th\u00e1ng 5, 2024<\/td>\n<td>B\u00e1o c\u00e1o Q1<\/td>\n<td>125,80 USD<\/td>\n<td>+6,60 (+5,25%)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Nh\u1eadn \u0110\u1ecbnh Xu H\u01b0\u1edbng:<\/strong> B\u00e1o c\u00e1o thu nh\u1eadp ng\u00e0y 4 th\u00e1ng 8 n\u0103m 2025 \u0111\u1eb7c bi\u1ec7t \u1ea5n t\u01b0\u1ee3ng &#8211; c\u00f4ng ty b\u00e1o c\u00e1o EPS l\u00e0 1,29 USD so v\u1edbi \u01b0\u1edbc t\u00ednh 1,08 USD (b\u1ea5t ng\u1edd 19,44%) v\u00e0 doanh thu 96,04 tri\u1ec7u USD so v\u1edbi \u01b0\u1edbc t\u00ednh 95,42 tri\u1ec7u USD (<a href=\"https:\/\/www.nasdaq.com\/articles\/krystal-biotech-inc-krys-tops-q2-earnings-and-revenue-estimates\">B\u00e1o c\u00e1o Nasdaq<\/a>). M\u1eb7c d\u00f9 hi\u1ec7u su\u1ea5t m\u1ea1nh m\u1ebd n\u00e0y, c\u1ed5 phi\u1ebfu ch\u1ec9 t\u0103ng 1,88%, cho th\u1ea5y kh\u1ea3 n\u0103ng b\u1ecb \u0111\u1ecbnh gi\u00e1 th\u1ea5p.<\/p>\n<h3>H\u00e0nh Tr\u00ecnh Gi\u00e1 6 Th\u00e1ng (Th\u00e1ng 2 &#8211; Th\u00e1ng 8 N\u0103m 2025)<\/h3>\n<p>Krystal Biotech \u0111\u00e3 tr\u1ea3i qua bi\u1ebfn \u0111\u1ed9ng \u0111\u00e1ng k\u1ec3 trong s\u00e1u th\u00e1ng qua:<\/p>\n<p><strong>Th\u00e1ng 2 n\u0103m 2025:<\/strong> 148,90 USD &#8211; K\u1ebft qu\u1ea3 h\u00e0ng n\u0103m m\u1ea1nh m\u1ebd t\u0103ng s\u1ef1 t\u1ef1 tin<br \/> <strong>Th\u00e1ng 3 n\u0103m 2025:<\/strong> 142,30 USD &#8211; S\u1ef1 \u0111i\u1ec1u ch\u1ec9nh th\u1ecb tr\u01b0\u1eddng \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn ng\u00e0nh c\u00f4ng ngh\u1ec7 sinh h\u1ecdc<br \/> <strong>Th\u00e1ng 4 n\u0103m 2025:<\/strong> 138,75 USD &#8211; \u00c1p l\u1ef1c ti\u1ebfp t\u1ee5c tr\u00ean to\u00e0n ng\u00e0nh<br \/> <strong>Th\u00e1ng 5 n\u0103m 2025:<\/strong> 142,10 USD &#8211; B\u00e1o c\u00e1o Q1 h\u1ed7 tr\u1ee3 gi\u00e1<br \/> <strong>Th\u00e1ng 6 n\u0103m 2025:<\/strong> 136,50 USD &#8211; Giai \u0111o\u1ea1n bi\u1ebfn \u0111\u1ed9ng m\u00f9a h\u00e8<br \/> <strong>Th\u00e1ng 7 n\u0103m 2025:<\/strong> 140,80 USD &#8211; B\u1eaft \u0111\u1ea7u ph\u1ee5c h\u1ed3i d\u1ea7n<br \/> <strong>Th\u00e1ng 8 n\u0103m 2025:<\/strong> 146,04 USD &#8211; M\u1ee9c hi\u1ec7n t\u1ea1i v\u1edbi s\u1ef1 t\u0103ng tr\u01b0\u1edfng t\u1eeb b\u00e1o c\u00e1o thu nh\u1eadp g\u1ea7n \u0111\u00e2y<\/p>\n<p>C\u1ed5 phi\u1ebfu \u0111\u00e3 gi\u1ea3m kho\u1ea3ng <strong>12,59%<\/strong> t\u1eeb \u0111\u1ea7u n\u0103m 2025 (<a href=\"https:\/\/companiesmarketcap.com\/krystal-biotech\/stock-price-history\/\">CompaniesMarketCap<\/a>), nh\u01b0ng \u0111i\u1ec1u n\u00e0y di\u1ec5n ra sau nh\u1eefng n\u0103m hi\u1ec7u su\u1ea5t xu\u1ea5t s\u1eafc &#8211; bao g\u1ed3m m\u1ee9c t\u0103ng 25,37% n\u0103m 2024 v\u00e0 l\u1ee3i nhu\u1eadn \u1ea5n t\u01b0\u1ee3ng 56,58% n\u0103m 2023.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/vt\/register\/\" class=\"po-cta-green\">B\u1eaft \u0111\u1ea7u giao d\u1ecbch\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udd2e D\u1ef1 B\u00e1o Gi\u00e1: Tri\u1ec3n V\u1ecdng 2025-2030<\/h2>\n<p>D\u1ef1a tr\u00ean d\u1ef1 b\u00e1o hi\u1ec7n t\u1ea1i c\u1ee7a c\u00e1c nh\u00e0 ph\u00e2n t\u00edch v\u00e0 n\u1ec1n t\u1ea3ng c\u00f4ng ty, \u0111\u00e2y l\u00e0 nh\u1eefng g\u00ec b\u1ea1n c\u00f3 th\u1ec3 mong \u0111\u1ee3i:<\/p>\n<ul>\n<li><strong>Cu\u1ed1i n\u0103m 2025:<\/strong> M\u1ee9c gi\u00e1 168-172 USD (t\u0103ng 15-18% so v\u1edbi m\u1ee9c hi\u1ec7n t\u1ea1i)<\/li>\n<li><strong>M\u1ee5c ti\u00eau 2026:<\/strong> 190-195 USD (t\u0103ng tr\u01b0\u1edfng ti\u1ec1m n\u0103ng 30-33%)<\/li>\n<li><strong>D\u1ef1 b\u00e1o 2028:<\/strong> 240-260 USD (t\u0103ng gi\u00e1 d\u00e0i h\u1ea1n 64-78%)<\/li>\n<li><strong>Tri\u1ec3n v\u1ecdng 2030:<\/strong> 295-320 USD (ti\u1ec1m n\u0103ng l\u1ee3i nhu\u1eadn t\u1ed5ng c\u1ed9ng 102-119%)<\/li>\n<\/ul>\n<p>D\u1ef1 b\u00e1o l\u1ea1c quan nh\u1ea5t \u0111\u1ebfn t\u1eeb <a href=\"https:\/\/stockscan.io\/stocks\/KRYS\/forecast\">StockScan<\/a>, d\u1ef1 \u0111o\u00e1n gi\u00e1 trung b\u00ecnh 264,25 USD n\u0103m 2025 v\u1edbi m\u1ee5c ti\u00eau cao nh\u1ea5t l\u00e0 300,56 USD.<\/p>\n<p><strong>K\u1ebft lu\u1eadn: MUA M\u1ea0NH<\/strong> &#8211; \u0110\u1ed3ng thu\u1eadn hi\u1ec7n t\u1ea1i c\u1ee7a c\u00e1c nh\u00e0 ph\u00e2n t\u00edch cho th\u1ea5y 11 nh\u00e0 ph\u00e2n t\u00edch \u0111\u00e1nh gi\u00e1 &#8220;Mua M\u1ea1nh&#8221; v\u1edbi m\u1ee5c ti\u00eau gi\u00e1 trung b\u00ecnh 205,27 USD, t\u01b0\u01a1ng \u1ee9ng ti\u1ec1m n\u0103ng t\u0103ng 40,60% (<a href=\"https:\/\/stockanalysis.com\/stocks\/krys\/forecast\/\">StockAnalysis<\/a>).<\/p>\n<h2>\u26a0\ufe0f R\u1ee7i Ro Ch\u00ednh v\u00e0 T\u00edn Hi\u1ec7u T\u00edch C\u1ef1c<\/h2>\n<h3>R\u1ee7i Ro C\u1ea7n L\u01b0u \u00dd<\/h3>\n<ul>\n<li><strong>Bi\u1ebfn \u0111\u1ed9ng cao:<\/strong> C\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc v\u1ed1n r\u1ea5t bi\u1ebfn \u0111\u1ed9ng &#8211; KRYS c\u00f3 ph\u1ea1m vi 52 tu\u1ea7n t\u1eeb 122,80 USD \u0111\u1ebfn 207,84 USD, t\u01b0\u01a1ng \u0111\u01b0\u01a1ng h\u01a1n 69% bi\u1ebfn \u0111\u1ed9ng<\/li>\n<li><strong>B\u1ea5t \u0111\u1ecbnh v\u1ec1 quy \u0111\u1ecbnh:<\/strong> Li\u1ec7u ph\u00e1p gen ch\u1ecbu s\u1ef1 gi\u00e1m s\u00e1t nghi\u00eam ng\u1eb7t c\u1ee7a FDA &#8211; b\u1ea5t k\u1ef3 tr\u1edf ng\u1ea1i n\u00e0o v\u1ec1 quy \u0111\u1ecbnh \u0111\u1ec1u c\u00f3 th\u1ec3 \u1ea3nh h\u01b0\u1edfng l\u1edbn \u0111\u1ebfn c\u1ed5 phi\u1ebfu<\/li>\n<li><strong>R\u1ee7i ro th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng:<\/strong> Ch\u01b0\u01a1ng tr\u00ecnh KB707 \u0111i\u1ec1u tr\u1ecb ung th\u01b0 ph\u1ed5i, d\u00f9 \u0111\u1ea7y h\u1ee9a h\u1eb9n, v\u1eabn \u0111ang trong giai \u0111o\u1ea1n \u0111\u1ea7u v\u00e0 c\u00f3 th\u1ec3 g\u1eb7p th\u00e1ch th\u1ee9c ph\u00e1t tri\u1ec3n<\/li>\n<li><strong>T\u00e2m l\u00fd th\u1ecb tr\u01b0\u1eddng:<\/strong> T\u00e2m l\u00fd ng\u00e0nh c\u00f4ng ngh\u1ec7 sinh h\u1ecdc v\u1eabn th\u1eadn tr\u1ecdng m\u1eb7c d\u00f9 n\u1ec1n t\u1ea3ng v\u1eefng ch\u1eafc<\/li>\n<\/ul>\n<h3>T\u00edn Hi\u1ec7u T\u00edch C\u1ef1c Cho 2025-2026<\/h3>\n<ul>\n<li><strong>T\u00e0i ch\u00ednh m\u1ea1nh m\u1ebd:<\/strong> Qu\u00fd 2 n\u0103m 2025 cho th\u1ea5y doanh thu t\u0103ng 37% so v\u1edbi c\u00f9ng k\u1ef3 l\u00ean 96,0 tri\u1ec7u USD v\u00e0 l\u1ee3i nhu\u1eadn r\u00f2ng t\u0103ng 146% l\u00ean 38,3 tri\u1ec7u USD<\/li>\n<li><strong>Li\u1ec7u ph\u00e1p \u0111\u1ed9t ph\u00e1:<\/strong> VYJUVEK l\u00e0 li\u1ec7u ph\u00e1p gen \u0111\u1ea7u ti\u00ean \u0111\u01b0\u1ee3c FDA ph\u00ea duy\u1ec7t cho b\u1ec7nh lo\u00e9t da b\u00f3ng n\u01b0\u1edbc d\u1ea1ng dystrophic, mang l\u1ea1i doanh thu b\u1ec1n v\u1eefng<\/li>\n<li><strong>Ti\u1ebfn tri\u1ec3n trong pipeline:<\/strong> Ch\u01b0\u01a1ng tr\u00ecnh KB707 d\u1ea1ng h\u00edt \u0111i\u1ec1u tr\u1ecb ung th\u01b0 ph\u1ed5i cho th\u1ea5y t\u1ef7 l\u1ec7 \u0111\u00e1p \u1ee9ng kh\u00e1ch quan 36% v\u00e0 h\u1ed3 s\u01a1 an to\u00e0n xu\u1ea5t s\u1eafc (<a href=\"https:\/\/www.pharmanow.live\/latest-news\/kb707-lung-cancer-update\">PharmaNow<\/a>)<\/li>\n<li><strong>H\u1ed7 tr\u1ee3 t\u1eeb nh\u00e0 ph\u00e2n t\u00edch:<\/strong> Ni\u1ec1m tin c\u1ee7a c\u00e1c t\u1ed5 ch\u1ee9c ng\u00e0y c\u00e0ng t\u0103ng v\u1edbi nhi\u1ec1u \u0111\u00e1nh gi\u00e1 &#8220;Mua M\u1ea1nh&#8221; h\u01a1n<\/li>\n<li><strong>Xu h\u01b0\u1edbng ng\u00e0nh:<\/strong> Th\u1ecb tr\u01b0\u1eddng li\u1ec7u ph\u00e1p gen d\u1ef1 ki\u1ebfn t\u0103ng tr\u01b0\u1edfng 26% h\u00e0ng n\u0103m trong ba n\u0103m t\u1edbi<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Nh\u00e0 Giao D\u1ecbch M\u1edbi N\u00ean L\u00e0m G\u00ec H\u00f4m Nay?<\/h2>\n<p>D\u1ef1a tr\u00ean ph\u00e2n t\u00edch c\u1ee7a t\u00f4i v\u1ec1 t\u1ea5t c\u1ea3 c\u00e1c y\u1ebfu t\u1ed1 n\u00e0y, \u0111\u00e2y l\u00e0 l\u1eddi khuy\u00ean c\u1ee7a t\u00f4i:<\/p>\n<ol>\n<li><strong>B\u1eaft \u0111\u1ea7u nh\u1ecf:<\/strong> B\u1eaft \u0111\u1ea7u v\u1edbi v\u1ecb th\u1ebf kh\u00f4ng v\u01b0\u1ee3t qu\u00e1 3-5% t\u1ed5ng danh m\u1ee5c \u0111\u1ea7u t\u01b0 c\u1ee7a b\u1ea1n<\/li>\n<li><strong>Trung b\u00ecnh gi\u00e1 mua:<\/strong> Thay v\u00ec mua m\u1ed9t l\u1ea7n, h\u00e3y chia nh\u1ecf c\u00e1c l\u1ea7n mua trong v\u00e0i tu\u1ea7n \u0111\u1ec3 trung b\u00ecnh gi\u00e1 v\u00e0o<\/li>\n<li><strong>\u0110\u1eb7t l\u1ec7nh d\u1eebng l\u1ed7:<\/strong> Do bi\u1ebfn \u0111\u1ed9ng cao, h\u00e3y b\u1ea3o v\u1ec7 kho\u1ea3n \u0111\u1ea7u t\u01b0 v\u1edbi m\u1ee9c d\u1eebng l\u1ed7 kho\u1ea3ng 135-140 USD<\/li>\n<li><strong>Theo d\u00f5i ng\u00e0y 3 th\u00e1ng 11:<\/strong> B\u00e1o c\u00e1o thu nh\u1eadp ti\u1ebfp theo c\u00f3 th\u1ec3 cung c\u1ea5p \u0111i\u1ec3m v\u00e0o t\u1ed1t h\u01a1n n\u1ebfu c\u00f3 s\u1ef1 suy y\u1ebfu t\u1ea1m th\u1eddi<\/li>\n<\/ol>\n<p>Ch\u00e2m ng\u00f4n h\u00e0i h\u01b0\u1edbc d\u00e0nh cho nh\u00e0 giao d\u1ecbch: &#8220;Mua c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc gi\u1ed1ng nh\u01b0 h\u1eb9n h\u00f2 &#8211; \u0111\u00f4i khi b\u1ea1n ph\u1ea3i ch\u1ecbu \u0111\u1ef1ng nh\u1eefng drama \u0111\u1ec3 t\u1eadn h\u01b0\u1edfng ph\u1ea7n th\u01b0\u1edfng m\u1ed1i quan h\u1ec7 l\u00e2u d\u00e0i!&#8221;<\/p>\n<h2>\u2705 C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Krystal Biotech, Inc. (KRYS) &#8211; T\u1eebng B\u01b0\u1edbc<\/h2>\n<table>\n<thead>\n<tr>\n<th>B\u01b0\u1edbc<\/th>\n<th>H\u00e0nh \u0110\u1ed9ng<\/th>\n<th>T\u1ea1i Sao Quan Tr\u1ecdng<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Ch\u1ecdn N\u1ec1n T\u1ea3ng Giao D\u1ecbch<\/td>\n<td>\u0110\u1ea3m b\u1ea3o n\u1ec1n t\u1ea3ng cung c\u1ea5p c\u1ed5 phi\u1ebfu ni\u00eam y\u1ebft tr\u00ean NASDAQ v\u00e0 c\u00f3 ph\u00ed h\u1ee3p l\u00fd<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>M\u1edf v\u00e0 N\u1ea1p Ti\u1ec1n V\u00e0o T\u00e0i Kho\u1ea3n<\/td>\n<td>B\u1eaft \u0111\u1ea7u v\u1edbi s\u1ed1 ti\u1ec1n b\u1ea1n c\u1ea3m th\u1ea5y tho\u1ea3i m\u00e1i r\u1ee7i ro &#8211; ngay c\u1ea3 100 USD c\u0169ng c\u00f3 th\u1ec3 gi\u00fap b\u1ea1n b\u1eaft \u0111\u1ea7u<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>T\u00ecm ki\u1ebfm &#8220;KRYS&#8221;<\/td>\n<td>S\u1eed d\u1ee5ng m\u00e3 ch\u1ee9ng kho\u00e1n, kh\u00f4ng ch\u1ec9 t\u00ean c\u00f4ng ty<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Ch\u1ecdn Lo\u1ea1i L\u1ec7nh<\/td>\n<td>D\u00f9ng l\u1ec7nh gi\u1edbi h\u1ea1n \u0111\u1ec3 ki\u1ec3m so\u00e1t gi\u00e1 v\u00e0o thay v\u00ec l\u1ec7nh th\u1ecb tr\u01b0\u1eddng<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Xem l\u1ea1i v\u00e0 X\u00e1c nh\u1eadn<\/td>\n<td>Ki\u1ec3m tra k\u1ef9 chi ti\u1ebft l\u1ec7nh v\u00e0 ph\u00ed hoa h\u1ed3ng tr\u01b0\u1edbc khi th\u1ef1c hi\u1ec7n<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>\u0110\u1eb7t C\u1ea3nh B\u00e1o Gi\u00e1<\/td>\n<td>Theo d\u00f5i kho\u1ea3n \u0111\u1ea7u t\u01b0 v\u1edbi th\u00f4ng b\u00e1o t\u1ef1 \u0111\u1ed9ng khi gi\u00e1 bi\u1ebfn \u0111\u1ed9ng l\u1edbn<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>L\u1eadp K\u1ebf Ho\u1ea1ch Tho\u00e1t L\u1ec7nh<\/td>\n<td>Quy\u1ebft \u0111\u1ecbnh tr\u01b0\u1edbc khi b\u1ea1n s\u1ebd ch\u1ed1t l\u1eddi ho\u1eb7c c\u1eaft l\u1ed7<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 T\u1ea1i Sao Pocket Option Ph\u00f9 H\u1ee3p V\u1edbi Nh\u00e0 \u0110\u1ea7u T\u01b0 M\u1edbi<\/h2>\n<p>\u0110\u1ed1i v\u1edbi nh\u1eefng ng\u01b0\u1eddi mu\u1ed1n b\u1eaft \u0111\u1ea7u h\u00e0nh tr\u00ecnh \u0111\u1ea7u t\u01b0 v\u1edbi Krystal Biotech, Pocket Option mang l\u1ea1i nhi\u1ec1u l\u1ee3i th\u1ebf:<\/p>\n<ul>\n<li><strong>S\u1ed1 ti\u1ec1n n\u1ea1p t\u1ed1i thi\u1ec3u ch\u1ec9 5 USD<\/strong> &#8211; ho\u00e0n h\u1ea3o \u0111\u1ec3 th\u1eed nghi\u1ec7m chi\u1ebfn l\u01b0\u1ee3c v\u1edbi r\u1ee7i ro th\u1ea5p<\/li>\n<li><strong>Quy tr\u00ecnh KYC nhanh nh\u01b0 ch\u1edbp<\/strong> &#8211; x\u00e1c minh ch\u1ec9 v\u1edbi m\u1ed9t t\u00e0i li\u1ec7u trong v\u00e0i ph\u00fat<\/li>\n<li><strong>H\u00e0ng tr\u0103m ph\u01b0\u01a1ng th\u1ee9c r\u00fat ti\u1ec1n<\/strong> bao g\u1ed3m ti\u1ec1n \u0111i\u1ec7n t\u1eed, v\u00ed \u0111i\u1ec7n t\u1eed v\u00e0 c\u00e1c ph\u01b0\u01a1ng th\u1ee9c ng\u00e2n h\u00e0ng truy\u1ec1n th\u1ed1ng<\/li>\n<li><strong>N\u1ec1n t\u1ea3ng th\u00e2n thi\u1ec7n v\u1edbi ng\u01b0\u1eddi d\u00f9ng<\/strong> thi\u1ebft k\u1ebf ri\u00eang cho ng\u01b0\u1eddi m\u1edbi v\u1edbi t\u00e0i nguy\u00ean gi\u00e1o d\u1ee5c<\/li>\n<\/ul>\n<p>R\u00e0o c\u1ea3n gia nh\u1eadp th\u1ea5p c\u1ee7a n\u1ec1n t\u1ea3ng l\u00e0m cho n\u00f3 l\u00fd t\u01b0\u1edfng cho c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 mu\u1ed1n x\u00e2y d\u1ef1ng v\u1ecb th\u1ebf d\u1ea7n d\u1ea7n trong khi h\u1ecdc v\u1ec1 \u0111\u1ea7u t\u01b0 c\u00f4ng ngh\u1ec7 sinh h\u1ecdc.<\/p>\n<h2>\ud83c\udf0d Krystal Biotech N\u0103m 2025: Ng\u01b0\u1eddi Ti\u00ean Phong Li\u1ec7u Ph\u00e1p Gen<\/h2>\n<p>Krystal Biotech \u0111\u00e3 kh\u1eb3ng \u0111\u1ecbnh m\u00ecnh l\u00e0 m\u1ed9t <strong>c\u00f4ng ty li\u1ec7u ph\u00e1p gen giai \u0111o\u1ea1n th\u01b0\u01a1ng m\u1ea1i<\/strong> v\u1edbi v\u1ed1n h\u00f3a th\u1ecb tr\u01b0\u1eddng kho\u1ea3ng 4,5 t\u1ef7 USD (<a href=\"https:\/\/www.bccresearch.com\/company-index\/profile\/krystal-biotech-inc\">BCC Research<\/a>). C\u00f4ng ty chuy\u00ean ph\u00e1t tri\u1ec3n c\u00e1c lo\u1ea1i thu\u1ed1c di truy\u1ec1n cho c\u00e1c b\u1ec7nh hi\u1ebfm s\u1eed d\u1ee5ng c\u00f4ng ngh\u1ec7 vector HSV-1 \u0111\u1ed9c quy\u1ec1n c\u1ee7a m\u00ecnh.<\/p>\n<p><strong>\u0110i\u1ec1u g\u00ec l\u00e0m h\u1ecd \u0111\u1eb7c bi\u1ec7t?<\/strong> N\u1ec1n t\u1ea3ng STAR-D c\u1ee7a h\u1ecd cho ph\u00e9p li\u1ec7u ph\u00e1p gen c\u00f3 th\u1ec3 t\u00e1i s\u1eed d\u1ee5ng &#8211; ngh\u0129a l\u00e0 b\u1ec7nh nh\u00e2n c\u00f3 th\u1ec3 nh\u1eadn nhi\u1ec1u l\u1ea7n \u0111i\u1ec1u tr\u1ecb m\u00e0 kh\u00f4ng ph\u00e1t tri\u1ec3n kh\u00e1ng th\u1ec3 mi\u1ec5n d\u1ecbch, m\u1ed9t b\u01b0\u1edbc \u0111\u1ed9t ph\u00e1 l\u1edbn trong l\u0129nh v\u1ef1c n\u00e0y.<\/p>\n<p>S\u1ea3n ph\u1ea9m ch\u1ee7 l\u1ef1c c\u1ee7a c\u00f4ng ty, VYJUVEK, l\u00e0 <strong>li\u1ec7u ph\u00e1p gen \u0111\u1ea7u ti\u00ean \u0111\u01b0\u1ee3c FDA ph\u00ea duy\u1ec7t<\/strong> cho b\u1ec7nh lo\u00e9t da b\u00f3ng n\u01b0\u1edbc d\u1ea1ng dystrophic, m\u1ed9t r\u1ed1i lo\u1ea1n da di truy\u1ec1n \u0111au \u0111\u1edbn v\u00e0 suy nh\u01b0\u1ee3c. Nh\u01b0ng \u0111i\u1ec1u th\u1ef1c s\u1ef1 g\u00e2y ph\u1ea5n kh\u00edch l\u00e0 pipeline c\u1ee7a h\u1ecd, \u0111\u1eb7c bi\u1ec7t l\u00e0 ch\u01b0\u01a1ng tr\u00ecnh KB707 cho ung th\u01b0 ph\u1ed5i kh\u00f4ng t\u1ebf b\u00e0o nh\u1ecf \u0111ang cho th\u1ea5y k\u1ebft qu\u1ea3 s\u1edbm \u0111\u00e1ng ch\u00fa \u00fd.<\/p>\n<h3>S\u1ef1 Th\u1eadt Th\u00fa V\u1ecb:<\/h3>\n<p>V\u00e0o th\u00e1ng 8 n\u0103m 2025, Krystal Biotech \u0111\u00e3 g\u00e2y ch\u00fa \u00fd khi \u01b0u ti\u00ean li\u1ec7u ph\u00e1p KB707 d\u1ea1ng h\u00edt cho ung th\u01b0 ph\u1ed5i sau khi n\u00f3 th\u1ec3 hi\u1ec7n t\u1ef7 l\u1ec7 \u0111\u00e1p \u1ee9ng 36% \u1edf b\u1ec7nh nh\u00e2n \u0111\u00e3 \u0111i\u1ec1u tr\u1ecb nhi\u1ec1u l\u1ea7n. \u0110i\u1ec1u g\u00ec th\u1ef1c s\u1ef1 \u0111\u00e1ng ch\u00fa \u00fd? Li\u1ec7u ph\u00e1p n\u00e0y c\u00f3 th\u1ec3 \u0111\u01b0\u1ee3c s\u1eed d\u1ee5ng trong m\u00f4i tr\u01b0\u1eddng ngo\u1ea1i tr\u00fa m\u00e0 kh\u00f4ng c\u00f3 t\u00e1c d\u1ee5ng ph\u1ee5 nghi\u00eam tr\u1ecdng &#8211; c\u00f3 kh\u1ea3 n\u0103ng c\u00e1ch m\u1ea1ng h\u00f3a kh\u1ea3 n\u0103ng ti\u1ebfp c\u1eadn \u0111i\u1ec1u tr\u1ecb ung th\u01b0 (<a href=\"https:\/\/www.globenewswire.com\/news-release\/2025\/08\/21\/3137361\/0\/en\/Krystal-Biotech-Announces-Update-on-Development-Plans-for-Oncology-Program-KB707-and-Prioritization-of-Inhaled-KB707-for-the-Treatment-of-Non-Small-Cell-Lung-Cancer.html\">GlobeNewswire<\/a>).<\/p>\n"},"faq":[{"question":"L\u00e0m th\u1ebf n\u00e0o \u0111\u1ec3 b\u1eaft \u0111\u1ea7u mua c\u1ed5 phi\u1ebfu KRYS?","answer":"B\u1ea1n c\u1ea7n ch\u1ecdn m\u1ed9t n\u1ec1n t\u1ea3ng giao d\u1ecbch h\u1ed7 tr\u1ee3 c\u1ed5 phi\u1ebfu NASDAQ, m\u1edf t\u00e0i kho\u1ea3n, n\u1ea1p ti\u1ec1n, t\u00ecm m\u00e3 KRYS, ch\u1ecdn lo\u1ea1i l\u1ec7nh, x\u00e1c nh\u1eadn giao d\u1ecbch v\u00e0 theo d\u00f5i gi\u00e1 v\u1edbi c\u1ea3nh b\u00e1o."},{"question":"KRYS c\u00f3 r\u1ee7i ro g\u00ec khi \u0111\u1ea7u t\u01b0?","answer":"C\u1ed5 phi\u1ebfu KRYS c\u00f3 bi\u1ebfn \u0111\u1ed9ng cao, ch\u1ecbu \u1ea3nh h\u01b0\u1edfng b\u1edfi quy \u0111\u1ecbnh FDA, r\u1ee7i ro th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng v\u00e0 t\u00e2m l\u00fd th\u1ecb tr\u01b0\u1eddng ng\u00e0nh c\u00f4ng ngh\u1ec7 sinh h\u1ecdc."},{"question":"Ti\u1ec1m n\u0103ng t\u0103ng tr\u01b0\u1edfng c\u1ee7a KRYS trong t\u01b0\u01a1ng lai ra sao?","answer":"D\u1ef1 b\u00e1o gi\u00e1 KRYS c\u00f3 th\u1ec3 t\u0103ng l\u00ean 168-172 USD cu\u1ed1i n\u0103m 2025 v\u00e0 l\u00ean \u0111\u1ebfn 295-320 USD v\u00e0o n\u0103m 2030, v\u1edbi ti\u1ec1m n\u0103ng l\u1ee3i nhu\u1eadn l\u1edbn."},{"question":"Li\u1ec7u ph\u00e1p gen VYJUVEK c\u00f3 g\u00ec \u0111\u1eb7c bi\u1ec7t?","answer":"VYJUVEK l\u00e0 li\u1ec7u ph\u00e1p gen \u0111\u1ea7u ti\u00ean \u0111\u01b0\u1ee3c FDA ph\u00ea duy\u1ec7t cho b\u1ec7nh lo\u00e9t da b\u00f3ng n\u01b0\u1edbc d\u1ea1ng dystrophic, mang l\u1ea1i doanh thu b\u1ec1n v\u1eefng cho c\u00f4ng ty."},{"question":"T\u1ea1i sao n\u00ean s\u1eed d\u1ee5ng Pocket Option \u0111\u1ec3 \u0111\u1ea7u t\u01b0 KRYS?","answer":"Pocket Option c\u00f3 s\u1ed1 ti\u1ec1n n\u1ea1p t\u1ed1i thi\u1ec3u th\u1ea5p, quy tr\u00ecnh KYC nhanh, nhi\u1ec1u ph\u01b0\u01a1ng th\u1ee9c r\u00fat ti\u1ec1n v\u00e0 n\u1ec1n t\u1ea3ng th\u00e2n thi\u1ec7n v\u1edbi ng\u01b0\u1eddi m\u1edbi, ph\u00f9 h\u1ee3p cho nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi b\u1eaft \u0111\u1ea7u."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"L\u00e0m th\u1ebf n\u00e0o \u0111\u1ec3 b\u1eaft \u0111\u1ea7u mua c\u1ed5 phi\u1ebfu KRYS?","answer":"B\u1ea1n c\u1ea7n ch\u1ecdn m\u1ed9t n\u1ec1n t\u1ea3ng giao d\u1ecbch h\u1ed7 tr\u1ee3 c\u1ed5 phi\u1ebfu NASDAQ, m\u1edf t\u00e0i kho\u1ea3n, n\u1ea1p ti\u1ec1n, t\u00ecm m\u00e3 KRYS, ch\u1ecdn lo\u1ea1i l\u1ec7nh, x\u00e1c nh\u1eadn giao d\u1ecbch v\u00e0 theo d\u00f5i gi\u00e1 v\u1edbi c\u1ea3nh b\u00e1o."},{"question":"KRYS c\u00f3 r\u1ee7i ro g\u00ec khi \u0111\u1ea7u t\u01b0?","answer":"C\u1ed5 phi\u1ebfu KRYS c\u00f3 bi\u1ebfn \u0111\u1ed9ng cao, ch\u1ecbu \u1ea3nh h\u01b0\u1edfng b\u1edfi quy \u0111\u1ecbnh FDA, r\u1ee7i ro th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng v\u00e0 t\u00e2m l\u00fd th\u1ecb tr\u01b0\u1eddng ng\u00e0nh c\u00f4ng ngh\u1ec7 sinh h\u1ecdc."},{"question":"Ti\u1ec1m n\u0103ng t\u0103ng tr\u01b0\u1edfng c\u1ee7a KRYS trong t\u01b0\u01a1ng lai ra sao?","answer":"D\u1ef1 b\u00e1o gi\u00e1 KRYS c\u00f3 th\u1ec3 t\u0103ng l\u00ean 168-172 USD cu\u1ed1i n\u0103m 2025 v\u00e0 l\u00ean \u0111\u1ebfn 295-320 USD v\u00e0o n\u0103m 2030, v\u1edbi ti\u1ec1m n\u0103ng l\u1ee3i nhu\u1eadn l\u1edbn."},{"question":"Li\u1ec7u ph\u00e1p gen VYJUVEK c\u00f3 g\u00ec \u0111\u1eb7c bi\u1ec7t?","answer":"VYJUVEK l\u00e0 li\u1ec7u ph\u00e1p gen \u0111\u1ea7u ti\u00ean \u0111\u01b0\u1ee3c FDA ph\u00ea duy\u1ec7t cho b\u1ec7nh lo\u00e9t da b\u00f3ng n\u01b0\u1edbc d\u1ea1ng dystrophic, mang l\u1ea1i doanh thu b\u1ec1n v\u1eefng cho c\u00f4ng ty."},{"question":"T\u1ea1i sao n\u00ean s\u1eed d\u1ee5ng Pocket Option \u0111\u1ec3 \u0111\u1ea7u t\u01b0 KRYS?","answer":"Pocket Option c\u00f3 s\u1ed1 ti\u1ec1n n\u1ea1p t\u1ed1i thi\u1ec3u th\u1ea5p, quy tr\u00ecnh KYC nhanh, nhi\u1ec1u ph\u01b0\u01a1ng th\u1ee9c r\u00fat ti\u1ec1n v\u00e0 n\u1ec1n t\u1ea3ng th\u00e2n thi\u1ec7n v\u1edbi ng\u01b0\u1eddi m\u1edbi, ph\u00f9 h\u1ee3p cho nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi b\u1eaft \u0111\u1ea7u."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>C\u00e1ch mua c\u1ed5 phi\u1ebfu Krystal Biotech, Inc. (KRYS) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Krystal Biotech, Inc. (KRYS)<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-krystal-biotech\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Krystal Biotech, Inc. (KRYS) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Krystal Biotech, Inc. (KRYS)\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-krystal-biotech\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-25T11:23:32+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-krystal-biotech\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-krystal-biotech\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Krystal Biotech, Inc. (KRYS) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Krystal Biotech, Inc. (KRYS)\",\"datePublished\":\"2025-08-25T11:23:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-krystal-biotech\/\"},\"wordCount\":23,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-krystal-biotech\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"vt-VT\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-krystal-biotech\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-krystal-biotech\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-krystal-biotech\/\",\"name\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Krystal Biotech, Inc. (KRYS) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Krystal Biotech, Inc. (KRYS)\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-krystal-biotech\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-krystal-biotech\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp\",\"datePublished\":\"2025-08-25T11:23:32+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-krystal-biotech\/#breadcrumb\"},\"inLanguage\":\"vt-VT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-krystal-biotech\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"vt-VT\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-krystal-biotech\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-krystal-biotech\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/vt\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Krystal Biotech, Inc. (KRYS) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Krystal Biotech, Inc. (KRYS)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/vt\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"vt-VT\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"vt-VT\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Krystal Biotech, Inc. (KRYS) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Krystal Biotech, Inc. (KRYS)","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-krystal-biotech\/","og_locale":"en_US","og_type":"article","og_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Krystal Biotech, Inc. (KRYS) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Krystal Biotech, Inc. (KRYS)","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-krystal-biotech\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-25T11:23:32+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-krystal-biotech\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-krystal-biotech\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Krystal Biotech, Inc. (KRYS) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Krystal Biotech, Inc. (KRYS)","datePublished":"2025-08-25T11:23:32+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-krystal-biotech\/"},"wordCount":23,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-krystal-biotech\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"vt-VT","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-krystal-biotech\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-krystal-biotech\/","url":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-krystal-biotech\/","name":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Krystal Biotech, Inc. (KRYS) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Krystal Biotech, Inc. (KRYS)","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-krystal-biotech\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-krystal-biotech\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp","datePublished":"2025-08-25T11:23:32+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-krystal-biotech\/#breadcrumb"},"inLanguage":"vt-VT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-krystal-biotech\/"]}]},{"@type":"ImageObject","inLanguage":"vt-VT","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-krystal-biotech\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-krystal-biotech\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/vt\/"},{"@type":"ListItem","position":2,"name":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Krystal Biotech, Inc. (KRYS) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Krystal Biotech, Inc. (KRYS)"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/vt\/#website","url":"https:\/\/pocketoption.com\/blog\/vt\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/vt\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"vt-VT"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"vt-VT","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/vt\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"vt_VT","wpml_translations":{"pt_AA":{"locale":"pt_AA","id":347258,"slug":"how-to-buy-krystal-biotech","post_title":"Como comprar a\u00e7\u00f5es da Krystal Biotech, Inc. (KRYS) - Investimento em a\u00e7\u00f5es da Krystal Biotech, Inc. (KRYS)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-krystal-biotech\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts\/347265","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/comments?post=347265"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts\/347265\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/media\/334009"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/media?parent=347265"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/categories?post=347265"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/tags?post=347265"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}